Premium Insight, Collaborative Learning & Mission-Focused Connections for Biopharma

Searchlight are expert networks focused on helping companies engaged in precise drug development niches make better decisions faster. Our expert life science networks facilitate solutions to shared R&D challenges that accelerate safer and more effective drugs to patients in need.

Searchlight provides a personalized quality service and access to a ready-made, hyper-relevant KOL network that delivers the critical insight, experience sharing and inspiration you need to make better drug development decisions, avoid costly mistakes, and save time.

Connect
Engage in year-round scientific exchange
Think
Access a greater diversity of expert scientific opinion
Grow
Challenge your thinking to make smarter decisions
Searchlight

ADC Discovery Searchlight

Accelerated ADC Discovery: Searchlight is a unique collective working to create the best-in-class ADC, optimize clinical trial design and uncover smarter approaches for problem-free scale up.
ADCs & Engineered Antibodies
Searchlight

Allogeneic Searchlight

Allogeneic Cell Therapy: Searchlight is a world-first consortium of allogeneic leaders working together to accelerate the translation and clinical development of allogeneic cell therapies.
Cell Therapy
Searchlight

GTx Searchlight

Gene Therapy for Rare Disorders: Searchlight is a vital year-round knowledge sharing and problem solving network designed to accelerate the safe delivery of gene therapies to rare disorder patients.
Gene Therapy
Searchlight

LEAP CHRO Searchlight

LEAP CHRO: Searchlight is an exclusive network of Life Science CHROs ​working together to get ahead of the key people challenges facing the biopharma industry.
Multiple Topics
Searchlight

LEAP HRBP Searchlight

LEAP HRBP: Searchlight is a ready-made, year round network of selected partners, alongside industry leading HR pioneers, to work through business critical challenges in a facilitated, structured and boundaryless way.
Multiple Topics
Searchlight

LEAP TA: Searchlight

LEAP TA: Searchlight is a collaborative community of the most strategic life sciences TA leaders sharing actionable ideas that can help find and retain better talent, faster.
Multiple Topics
Searchlight

Microbiome Drug Development Searchlight

Microbiome Drug Development: Searchlight is a global network of microbiome leaders united in optimizing positive clinical outcomes to accelerate safe, effective and approved microbiome-based therapeutics to patients.
Microbiome
Searchlight

mRNA Searchlight

mRNA-based Therapeutics Searchlight is a critical problem solving network of mRNA therapeutic developers focused on accelerating the delivery of safe and effective mRNA-based therapeutics to patients.
RNA Therapy
Searchlight

RAS Searchlight

RAS-Targeted Therapies: Searchlight is the world’s first network designed to provide a continuous flow of timely insights and valuable experiences to develop therapies for RAS-driven cancers.
Protein Degradation
Searchlight

TPD Searchlight

Targeted Protein Degradation: Searchlight is a network of TPD leaders united in scientific exchange to solve critical shared problems and progress effective protein degraders through the clinic.
Protein Degradation

Members

Be inspired by forward-thinking leaders. Grow beyond your perceived limits. Connect with compatible members with shared challenges. Redefine and realize your business goals with Searchlight by Hanson Wade.

Zoom-Call-1@3x-768x376
Testimonials

“This network brings me such value because it allows me to work with brilliant people to tackle shared challenges together.”

Sally Paull
Chief Human Resources Officer, Regeneron
Placeholder Image

“It’s just not efficient for individual companies to work in isolation to solve the common problems we share, which makes this so vital.”

Steve Kelsey
President - Research & Development, revolution Medicines
Placeholder Image

“Our long term strategy has been directly influenced by what we’ve heard our peers thinking about and doing in our network.”

Stephanie Franklin
Chief Human Resources Officer, Vertex Pharmaceuticals
Placeholder Image

“There is a huge benefit for us all of us in the strategic exchange of what’s working – and what’s not – in the fast-moving field in which we’re engaged.”

Oliver Kraemer
Head of Gene Edited Platforms, Bristol Myers Squibb
Placeholder Image

True Innovation Can’t Happen in Isolation

Gain access to a ready-made KOL network that delivers the critical insight, experience sharing, and inspiring connections you need to make better drug development decisions, at speed.